Join to View Full Profile
166 E 96th StApt 17aNew York, NY 10128
Phone+1 212-644-2610
Fax+1 212-923-5700
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 6 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Seth Lederman, MD is a rheumatologist in New York, New York. He is currently licensed to practice medicine in New York.
Education & Training
Columbia University Vagelos College of Physicians and SurgeonsClass of 1983
Certifications & Licensure
NY State Medical License 1985 - 2026
Publications & Presentations
PubMed
- 4 citationsPredictors of Response to Prolonged Exposure, Sertraline, and Their Combination for the Treatment of Military PTSD.Sheila A.M. Rauch, H. Myra Kim, Seth Lederman, Gregory M. Sullivan, Ron Acierno
The Journal of Clinical Psychiatry. 2021-06-15 - 7 citationsRandomized clinical trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related PTSD and the role of sleep quality in treatment response.Gregory M. Sullivan, R. Michael Gendreau, Judith Gendreau, Perry Scott Peters, Ashild Peters
Psychiatry Research. 2021-04-30 - 134 citationsConstruction of an infectious horsepox virus vaccine from chemically synthesized DNA fragmentsRyan S. Noyce, Seth Lederman, David H. Evans
Plos One. 2018-01-19
Press Mentions
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in FibromyalgiaMarch 4th, 2025- Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation Anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune DiseasesFebruary 6th, 2025
- FDA to Review Sublingual Cyclobenzaprine for Fibromyalgia ManagementDecember 17th, 2024
- Join now to see all
